ReviewFrontiers in pharmacology2025
Tumor-like characteristics of vascular smooth muscle cells in atherosclerosis.
Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- CD8Nature reviews. Cardiology · 2026Review
- SIRT1 in Atherosclerosis: Integrative Control of Vascular Metabolism, Inflammation and Aging.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atherosclerosis is a complex, chronic inflammatory disease, traditionally considered a lipid-driven and immune-mediated disorder whose pathogenesis involves the interplay of multiple cellular populations. Vascular smooth muscle cells (SMCs) have long been considered contractile and extracellular matrix-producing cells that stabilize the fibrous cap. However, recent advances in lineage tracing and single-cell transcriptomics have revealed that vascular SMCs possess a high degree of plasticity and exhibit tumor-like characteristics during atherogenesis. Vascular SMCs and vascular smooth muscle cell-derived cells (SDCs) in atherogenesis exhibit DNA damage and genomic instability, evade senescence, hyperproliferate, activation of migration and invasion, cancer stem cell-like property, and activate multiple cancer-related signaling pathways. These tumor-like behaviors accelerate phenotypic switching of vascular SMCs and lesion progression. In this review, we mainly discuss the tumor-like characteristics of vascular SMCs, aiming to provide a theoretical basis for new therapeutic strategies targeting vascular SMCs and provide new ideas for the precise prevention and treatment of atherosclerosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.